Physician profile
Renalda Dashi
NPI 1538892310
$5,976.12
in general payments reported to CMS, 2019-2025
39 companies · $5,207 in 2025
The $5,207 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.90 · 2023: $295 · 2024: $454 · 2025: $5,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,590 · Travel and Lodging: $1,323 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,590.13 |
| Travel and Lodging | $1,322.59 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,995.81 | 2025 | Minimed 780g |
| Cequr Corporation | $962.53 | 2025 | Cequr Simplicity |
| Novo Nordisk INC | $379.31 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Mannkind Corporation | $264.37 | 2025 | |
| Novartis Pharmaceuticals Corporation | $230.12 | 2023-2024 | |
| Cordis US Corp. | $225.32 | 2023-2025 | Brite Tip Radianz, Wizdom, S.M.A.R.T. Control |
| Corcept Therapeutics | $196.37 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $181.34 | 2023-2025 | |
| Sequel Med Tech, LLC | $167.99 | 2025 | Twiist |
| Beta Bionics, INC. | $155.09 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Terumo Medical Corporation | $110.24 | 2024 | Azur Cx Detachable, Angio-Seal |
| Abbott Laboratories | $106.27 | 2025 | Freestyle Libre 3 |
| Madrigal Pharmaceuticals | $103.27 | 2025 | Rezdiffra |
| Lilly USA, LLC | $94.22 | 2025 | Zepbound, Mounjaro |
| Abbvie INC. | $71.34 | 2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renalda Dashi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.